News and Press Releases
Phase 2b Influenza Field Study Contract
hVIVO to enrol up to 1,000 healthy volunteers as part of a multicentre field study testing an influenza drug candidate, with hVIVO selected as the sole UK clinical site Largest...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 2, 2024
Clinigen appoints Fernando Ballester as Chief Financial Officer
2 July 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces the appointment of Fernando Ballester as chief financial officer (CFO), effective 1 August 2024. Fernando,...
Category: Other, Pharmaceutical
Posted: July 2, 2024
CN Bio appoints Lydia Seymour as VP People and Culture to further strengthen leadership team
Key appointment to support continued UK and US team expansion 27 June 2024 -- Cambridge, UK -- CN Bio, a leading provider of single- and multi-organ microphysiological systems, today announced...
Category: Biotechnology, Other, Pharmaceutical
Posted: June 27, 2024
Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation
26 June 2024 -- South Carolina, US -- Avallano, an AI-enabled clinical research company, today announced the appointment of Michael A Ibara PharmD, as chief strategy officer (CSO). Dr Ibara...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 26, 2024
X-Chem Strengthens Its Data-Driven Discovery Services
With new CBO appointment industry veteran Paul Davie joins X-Chem executive team to lead strategic growth and partnerships 20 June 2024 -- Massachusetts, US -- Small molecule drug discovery acceleration...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: June 20, 2024
Mage Biologics announces first subject dosed in a phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease
12 June 2024 -- Delaware, US -- Mage Biologics announces it has dosed the first study participant in a first-in-human study of MB-001, a best-in-class orally administered antibody designed for...
Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: June 19, 2024
Enterprise Therapeutics appoints Dr Renu Gupta as chief medical officer and Dr Janet Hammond as non-executive director
Appointments bring additional respiratory and late clinical-stage drug development experience as company commences Phase 2a clinical trial of its lead asset 17 June 2024, Brighton, UK -: Enterprise Therapeutics Ltd...
Category: Biotechnology, Pharmaceutical
Posted: June 17, 2024
Sussex Innovation Centre, University of Sussex, Science Park Square, Falmer, Brighton, BN1 9SB, UK
Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting
PPD clinical research business leads real-world data and technology panel, receives CRO Leadership Award 17 June 2024 -- California, US -- The PPD clinical research business of Thermo Fisher Scientific,...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 17, 2024
Formycon reports on the results of the annual general meeting
Management provides detailed report on financial year 2023 and current company performance. Shareholders approve all agenda items and formally approve the acts of the members of the management board and...
Category: BioManufacturing
Posted: June 13, 2024
Deep Genomics Expands Executive Leadership and Operations in Latest Strategic Growth Initiative
Company announces executive new hires and marks significant momentum with Cambridge, Massachusetts, US, site opening and Toronto, Canada, office expansion 13 June 2024 -- Massachusetts, US -- Deep Genomics, the...
Category: Biotechnology, Other, Pharmaceutical
Posted: June 13, 2024
480 University Ave, Suite 1300 Toronto, Ontario, Canada, M5G 1V2
Newcells Biotech strengthens executive and US team with key appointments
Dr Valeria Chichagova appointed as director of technology, Dr Colin Brown as chief scientific officer, and Professor Lyle Armstrong as scientific advisor New US commercial appointments also announced to meet...
Category: Biotechnology
Posted: June 11, 2024
Newcells Biotech, The Biophere, Drayman's Way, newcastle Helix, Newcastle-upon-Tyne, NE4 5BX
Altasciences Receives 2024 CRO Leadership Award for Capabilities
16 May 2024 -- Laval, Québec, Canada -- Altasciences announced today that it has been recognised for excellence in contract research with a 2024 CRO Leadership Award for Capabilities. This...
Category: BioManufacturing, Clinical Trials, Pharmaceutical
Posted: June 3, 2024
TMC welcomes Joe Lopez as Chief Financial Officer (CFO) to enhance corporate C-level team
3 June 2024 -- Hampshire, UK -- TMC Pharma Services, an established global product development and clinical research organisation (CRO) headquartered in Hampshire, UK, is pleased to announce the appointment...
Category: Clinical Trials, Pharmaceutical
Posted: June 3, 2024
Lodge Farm Barn Elvetham Park Estate, Fleet Road, Hartley Wintney, Hampshire RG27 8AS, UK
Michael McSorley appointed as new managing director of Origin
3 June 2024 -- Melton, UK -- Global pharmaceutical solutions provider, Origin, has today appointed Michael McSorley as new managing director. Michael McSorley With almost a decade’s experience in the...
Category: Logistics, Manufacturing and Packing
Posted: June 3, 2024
Ardena appoints Jeremie Trochu as Chief Executive Officer
3 June 2024 -- Ghent, Belgium -- Ardena today announces the retirement of Harry Christiaens PhD, and the subsequent appointment of Jeremie Trochu as chief executive officer. Jeremie is a...
Category: BioManufacturing, Biotechnology, Logistics, Manufacturing and Packing, Pharmaceutical
Posted: June 3, 2024
